Matrix Metalloproteinase-1 Polymorphism is Associated with Persistent Airway Obstruction in Asthma in the Taiwanese Population

References

• Lange P, Parner J, Vestbo J, Schnohr P, Jensen G A. 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194–1200
   PubMed Web of Science ®Google Scholar
• Brown P J, Greville H W, Finucane K E. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131–136
   PubMed Web of Science ®Google Scholar
• Ulrik C S, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: Factors important for the decline in lung function. Thorax 1992; 47: 14–18
   PubMed Web of Science ®Google Scholar
• Chung K F, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, Burney P, Chanez P, Connett G, Corrigan C, de Blic J, Fabbri L, Holgate S T, Ind P, Joos G, Kerstjens H, Leuenberger P, Lofdahl C G, M'Kenzie S, Magnussen H, Postma D, Saetta M, Salmeron S, Sterk P. Difficult/therapy-resistant asthma: The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS task force on difficult/therapy-resistant asthma. European Respiratory Society. Eur Respir J 1999; 13: 1198–1208
   PubMed Web of Science ®Google Scholar
• Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 2000; 162: 2341–2351
   PubMedGoogle Scholar
• Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: A 1-yr prospective study. Eur Respir J 2002; 19: 61–67
   PubMed Web of Science ®Google Scholar
• Wenzel S E, Szefler S J, Leung D Y, Sloan S I, Rex M D, Martin R J. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156: 737–743
   PubMed Web of Science ®Google Scholar
• Jatakanon A, Uasuf C, Maziak W, Lim S, Chung K F, Barnes P J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532–1539
   PubMed Web of Science ®Google Scholar
• Redington A E, Howarth P H. Airway wall remodelling in asthma. Thorax 1997; 52: 310–312
   PubMed Web of Science ®Google Scholar
• ten Brinke A, Zwinderman A H, Sterk P J, Rabe K F, Bel E H. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744–748
   PubMed Web of Science ®Google Scholar
• Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes P J, Robinson D, Chung K F. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004; 24: 122–128
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner J F, Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491–21494
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003; 92: 827–839
   PubMed Web of Science ®Google Scholar
• Imai K, Dalal S S, Chen E S, Downey R, Schulman L L, Ginsburg M, D'Armiento J. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001; 163: 786–791
   PubMed Web of Science ®Google Scholar
• Cataldo D D, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart J M, Noel A, Louis R. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mrna transcripts in the bronchial secretions of asthmatics. Lab Invest 2004; 84: 418–424
   PubMed Web of Science ®Google Scholar
• Buttice G, Duterque-Coquillaud M, Basuyaux J P, Carrere S, Kurkinen M, Stehelin D. Erg, an ets-family member, differentially regulates human collagenase1 (MMP 1) and stromelysin1 (MMP 3) gene expression by physically interacting with the fos/jun complex. Oncogene 1996; 13: 2297–2306
   PubMed Web of Science ®Google Scholar
• Rutter J L, Mitchell T I, Buttice G, Meyers J, Gusella J F, Ozelius L J, Brinckerhoff C E. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an ets binding site and augments transcription. Cancer Res 1998; 58: 5321–5325
   PubMed Web of Science ®Google Scholar
• Kuo H P, Wang Y M, Wang C H, He C C, Lin S M, Lin H C, Liu C Y, Huang K H, Hsieh L L, Huang C D. Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. Tuberculosis (Edinb) 2008; 88: 262–267
   PubMed Web of Science ®Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS board of directors, November 1986. Am Rev Respir Dis 1987; 136: 225–244
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch E. F., Maniatis T. Molecular cloning. A laboratory manual. 2nd edition. Cold Spring Harbor Press, Cold Spring Harbor, NY 1989
   Google Scholar
• Joos L, He J Q, Shepherdson M B, Connett J E, Anthonisen N R, Pare P D, Sandford A J. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11: 569–576
   PubMed Web of Science ®Google Scholar
• Weiner P, Magadle R, Waizman J, Weiner M, Rabner M, Zamir D. Characteristics of asthma in the elderly. Eur Respir J 1998; 12: 564–568
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Kuprys I, Gorski P, Kuna P. Long-term deterioration of lung function in asthmatic outpatients. Respiration 2004; 71: 233–240
   PubMed Web of Science ®Google Scholar
• Hudon C, Turcotte H, Laviolette M, Carrier G, Boulet L P. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol 1997; 78: 195–202
   PubMed Web of Science ®Google Scholar
• Global strategy for asthma management and prevention (update 2007): Global initiative for asthma (GINA). 2007, Available at: http://www.ginasthma.org
   Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(updated 2007): Global initiative for chronic obstructive lung disease (GOLD). 2007, Available at: http://www.goldcopd.org
   Google Scholar
• Kornman K S, Crane A, Wang H Y, di Giovine F S, Newman M G, Pirk F W, Wilson T G, Jr., Higginbottom F L, Duff G W. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72–77
   PubMed Web of Science ®Google Scholar
• Yao T C, Kuo M L, See L C, Chen L C, Yan D C, Ou L S, Shaw C K, Huang J L. The rantes promoter polymorphism: A genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol 2003; 111: 1285–1292
   PubMed Web of Science ®Google Scholar
• Jongepier H, Boezen H M, Dijkstra A, Howard T D, Vonk J M, Koppelman G H, Zheng S L, Meyers D A, Bleecker E R, Postma D S. Polymorphisms of the ADAM 33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy 2004; 34: 757–760
   PubMed Web of Science ®Google Scholar
• Ueda T, Niimi A, Matsumoto H, Takemura M, Yamaguchi M, Matsuoka H, Jinnai M, Chin K, Minakuchi M, Cheng L, et al. TGF-b1 promoter polymorphism C-509T and pathophysiology of asthma. J Allergy Clin Immunol 2008; 121: 659–664
   PubMed Web of Science ®Google Scholar
• D'Armiento J, Dalal S S, Okada Y, Berg R A, Chada K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992; 71: 955–961
   PubMed Web of Science ®Google Scholar
• Noll W W, Belloni D R, Rutter J L, Storm C A, Schned A R, Titus-Ernstoff L, Ernstoff M S, Brinckerhoff C E. Loss of heterozygosity on chromosome 11q22–23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol 2001; 158: 691–697
   PubMed Web of Science ®Google Scholar
• Ninomiya S, Niimi T, Shimizu S, Sato S, Achiwa H, Ito H, Akita K, Maeda H, Ueda R. Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 19–24
   PubMed Web of Science ®Google Scholar
• Wiencke K, Louka A S, Spurkland A, Vatn M, Schrumpf E, Boberg K M. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 2004; 41: 209–214
   PubMed Web of Science ®Google Scholar
• Kurzawski M, Drozdzik A, Dembowska E, Pawlik A, Banach J, Drozdzik M. Matrix metalloproteinase-1 gene polymorphism in renal transplant patients with and without gingival enlargement. J Periodontol 2006; 77: 1498–1502
   PubMed Web of Science ®Google Scholar
• Hettiaratchi A, Hawkins N J, McKenzie G, Ward R L, Hunt J E, Wakefield D, Di Girolamo N. The collagenase-1 (MMP-1) gene promoter polymorphism – 1607/2g is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer 2007; 96: 783–792
   PubMed Web of Science ®Google Scholar
• Vairaktaris E, Yapijakis C, Derka S, Serefoglou Z, Vassiliou S, Nkenke E, Ragos V, Vylliotis A, Spyridonidou S, Tsigris C, et al. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 2007; 27: 459–464
   PubMed Web of Science ®Google Scholar